Cargando…
Increased SEMA6B expression as a potential prognostic and immune cell infiltration biomarker in thyroid cancer patients
Background: Even today, thyroid cancer (THCA) remains an important threat to global health. For THCA patients, differentiated thyroid cancer is the most commonly identified pathological subtype, and those diagnosed with papillary thyroid cancer generally have good overall prognosis. For poorly diffe...
Autores principales: | Lei, Qinghua, Wang, Yunha, Li, Junhua, Wang, Shanshan, Hu, Yanyan, Duan, Lihua, Huo, Yanfei, Wu, Yiping, Liu, Hongzhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449300/ https://www.ncbi.nlm.nih.gov/pubmed/37155149 http://dx.doi.org/10.18632/aging.204691 |
Ejemplares similares
-
Sema6B, Sema6C, and Sema6D Expression and Function during Mammalian Retinal Development
por: Matsuoka, Ryota L., et al.
Publicado: (2013) -
Remote neuronal activity drives glioma infiltration via Sema4f
por: Huang-Hobbs, Emmet, et al.
Publicado: (2023) -
IMMU-29. AIF1 IS A PROGNOSTIC BIOMARKER AND CORRELATED WITH IMMUNE INFILTRATES IN GLIOMAS
por: Chai, Yi, et al.
Publicado: (2020) -
ERBB2 as a prognostic biomarker correlates with immune infiltrates in papillary thyroid cancer
por: Jin, Yuchen, et al.
Publicado: (2022) -
APOE Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Papillary Thyroid Carcinoma
por: Lin, Xu, et al.
Publicado: (2022)